Product Description
Brand Mindray
Sample Type Serum
Pack Size 2 x 50T, 2 x 100T
CAT No 10500420800, 10500423500
Application Immuno-Assay
Ourchemiluminescence immunoassay reagentshave been specially developed to work with Mindray's CL series automatic chemiluminescence immunoassay analyzers to make a complete system, offering high reliability and accuracy. Mindray uses liquid, ready-to-use reagents which come in two packages, 50 tests and 100 tests, to suit customers with different requirements.
Rapid, Reliable Insulin QuantificationThe Mindray Insulin (CLIA) kit leverages advanced chemiluminescence technology for rapid and highly sensitive insulin quantification. Designed for seamless integration with Mindray CL-series analyzers, this reagent provides precise results in as little as 15-30 minutes, allowing clinics to optimize their diagnostic workflows. Automated interpretation ensures consistency and reliability while reducing manual intervention.
User-Friendly and Ready for Immediate UseWith a ready-to-use formulation, the Mindray Insulin (CLIA) kit streamlines laboratory operations and eliminates lengthy preparation steps. Its compatibility with a range of Mindray analyzers and ability to process serum or plasma samples make it an ideal solution for routine testing, supporting efficiency and ease of use in busy clinical diagnostic environments.
Safety and Quality AssuranceThis assay kit is IVD certified and strictly designed for clinical laboratory use, ensuring compliance with regulatory standards. Stored safely at 2C-8C, it boasts a 12-month shelf life. High sensitivity and specificity deliver confidence during quantitation, while the robust interpretative process through automated analyzer readings maximizes accuracy and reproducibility.
FAQ's of Mindray Insulin (CLIA):
Q: How is the Mindray Insulin (CLIA) reagent kit used in clinical laboratories?
A: The reagent kit is designed for use with Mindray CL-series CLIA analyzers. Laboratory personnel simply load serum or plasma samples into the analyzer along with the kit reagents. The system automatically processes the sample and produces quantitative insulin results, minimizing manual handling.
Q: What samples are suitable for testing with this kit, and what is the recommended storage condition?
A: This assay is validated for use with human serum or plasma samples. The reagent kit should be stored in a refrigerator at 2C-8C to preserve its stability and along with a 12-month shelf life when stored correctly.
Q: When can laboratories expect to receive results after running the assay?
A: Typical reaction time ranges from 15 to 30 minutes, depending on the specific Mindray CL-series analyzer in use. This allows laboratories to obtain results quickly and efficiently for timely clinical decision-making.
Q: What technology underlies the Mindray Insulin (CLIA) kit, and what are the benefits?
A: The kit employs chemiluminescence immunoassay (CLIA) technology using a sandwich methodology. This approach ensures high sensitivity, specificity, and the capability to provide quantitative results within the clinically relevant insulin concentration range.
Q: Where can the Mindray Insulin (CLIA) reagent kit be procured in India?
A: This product is available through various authorized dealers, distributors, exporters, manufacturers, suppliers, traders, and wholesalers across India. Please refer to Mindray's official channels for a list of local partners.
Q: What precautions should be taken while handling and operating this reagent kit?
A: The kit should only be used by trained laboratory personnel within a clinical diagnostic environment. Always adhere to the instructions outlined in the kit's IFU (Instructions for Use) and ensure proper storage conditions. The process is largely automated to ensure user safety and assay accuracy.
Q: What are the main advantages of using the Mindray Insulin (CLIA) kit over traditional methods?
A: The kit offers rapid turnaround, high precision, minimal manual steps due to automatic operation, and robust sensitivity and specificity, all of which contribute to enhanced workflow efficiency and reliable patient monitoring in clinical settings.